← Back to all trials
Completed
NCT06642610
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
Conditions: Prediabetes, Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
Sex: All
Ages: 12 Years – 55 Years
Healthy volunteers: No
Phase: NA
Enrollment: 14
Sponsor: Indiana University
Location: Indiana University Health, University Hospital Indianapolis Indiana
Summary
The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
Eligibility Criteria
Inclusion Criteria:
* CF individuals aged 12-55 years.
* CF without diabetes or with prediabetes (as defined by OGTT and HbA1c).
* Willing to use a continuous glucose monitoring system with compatible smart phone for glucose data collection.
A person with CFRD and already using CGM, we will just collect their personal CGM data, and they are not required to have OGTT or HbA1c visit.
Exclusion Criteria:
* Pregnancy.
* History of transplant.
* Use of immunosuppressant drugs.
* Use of oral steroids or any medication known to interfere with glucose.
* Allergy to adhesives.
* Individuals with severe concurrent medical conditions that could confound glucose monitoring data (e.g., terminal illness, major organ failure).
* Conditions that may make unsafe for participants to do study or impair or confound the study at the discretion of the investigator
Source: ClinicalTrials.gov (NCT06642610). StuddyBuddy aggregates publicly available trial information.
